blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0813424

EP0813424 - ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING A PROTON PUMP INHIBITOR AND AN ANTACID AGENT OR ALGINATE [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  03.07.2009
Database last updated on 29.10.2024
Most recent event   Tooltip17.04.2015Change - lapse in a contracting statepublished on 20.05.2015  [2015/21]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2000/19]
Former [1997/52]For all designated states
Astra Aktiebolag
151 85 Södertälje / SE
Inventor(s)01 / DEPUI, Helene
Wrangelsgatan 7B
S-416 62 Göteborg / SE
02 / HALLGREN, Agneta
Hökegärdsgatan 2C
S-431 38 Mölndal / SE
 [2002/47]
Former [1997/52]01 / DEPUI, Helene
Wrangelsgatan 7B
S-416 62 Göteborg / SE
02 / HALLGREN, Agneta
Hökeg rdsgatan 2C
S-431 38 Mölndal / SE
Application number, filing date96944726.720.12.1996
[1997/52]
WO1996SE01737
Priority number, dateSE1996000007108.01.1996         Original published format: SE 9600071
[1997/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9725066
Date:17.07.1997
Language:EN
[1997/31]
Type: A1 Application with search report 
No.:EP0813424
Date:29.12.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 17.07.1997 takes the place of the publication of the European patent application.
[1997/52]
Type: B1 Patent specification 
No.:EP0813424
Date:20.11.2002
Language:EN
[2002/47]
Type: B2 New European patent specification 
No.:EP0813424
Date:05.08.2009
Language:EN
[2009/32]
Search report(s)International search report - published on:SE17.07.1997
ClassificationIPC:A61K45/06, A61K31/44, A61K33/08, A61K33/10, A61K9/20, A61K9/26, A61P1/04
[2002/01]
CPC data not yet available
Former IPC [1997/52]A61K45/06, A61K31/44, A61K33/08, A61K33/10, A61K9/20, A61K9/26
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/52]
Extension statesLT08.10.1997
LV08.10.1997
RO08.10.1997
SI08.10.1997
TitleGerman:ORALE, PHARMAZEUTISCHE DARREICHUNGSFORMEN, DIE EINEN PROTONENPUMPENINHIBITOR UND EIN ANTACIDUM ODER ALGINAT ENTHALTEN[2002/01]
English:ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING A PROTON PUMP INHIBITOR AND AN ANTACID AGENT OR ALGINATE[1997/52]
French:FORMES GALENIQUES PAR VOIE ORALE COMPRENANTS UN INHIBITEUR DE LA POMPE A PROTONS ET UN AGENT ANTACIDE OU UN ALGINATE[2002/01]
Former [1997/52]ORALE, PHARMAZEUTISCHE DARREICHUNGSFORMEN DIE EINE PROTONENPUMPENINHIBITOR UND EINEN ANTACIDA ODER ALGINAT ENTHÄLTEN
Former [1997/52]FORMES GALENIQUES PAR VOIE ORALE COMPRENANT UN INHIBITEUR DE LA POMPE A PROTONS ET UN AGENT ANTIACIDE OU UN ALGINATE
Entry into regional phase08.10.1997National basic fee paid 
08.10.1997Designation fee(s) paid 
19.01.1998Examination fee paid 
Examination procedure19.01.1998Examination requested  [1998/12]
19.02.2001Despatch of a communication from the examining division (Time limit: M04)
19.06.2001Reply to a communication from the examining division
10.08.2001Despatch of a communication from the examining division (Time limit: M04)
23.10.2001Reply to a communication from the examining division
23.11.2001Despatch of communication of intention to grant (Approval: No)
22.03.2002Despatch of communication of intention to grant (Approval: later approval)
22.07.2002Communication of intention to grant the patent
22.08.2002Fee for grant paid
22.08.2002Fee for publishing/printing paid
Opposition(s)Opponent(s)01  07.08.2003  22.09.2003  ADMISSIBLE
Reckitt Benckiser Healthcare (UK) Limited
103-105 Bath Road
Slough Bershire SL1 3UH / GB
Opponent's representative
Brierley, Anthony Paul, et al, et al
Appleyard Lees
15 Clare Road
Halifax
HX1 2HY / GB
 [N/P]
Former [2006/44]
Opponent(s)01  07.08.2003  22.09.2003  ADMISSIBLE
Reckitt Benckiser Healthcare (UK) Limited
103-105 Bath Road
Slough Bershire SL1 3UH / GB
Opponent's representative
Brierley, Anthony Paul, et al, et al
Appleyard Lees 15 Clare Road
GB-Halifax, West Yorkshire HX1 2HY / GB
Former [2005/18]
Opponent(s)01  07.08.2003  22.09.2003  ADMISSIBLE
Reckitt Benckiser Healthcare (UK) Limited
103-105 Bath Road
Slough Bershire SL1 3UH / GB
Opponent's representative
Instone, Terry, et al, et al
Reckitt Benckiser plc, Intellectual Property Department - Patents Group, Dansom Lane
Hull HU8 7DS / GB
Former [2003/40]
Opponent(s)01  07.08.2003  22.09.2003  ADMISSIBLE
Reckitt Benckiser (UK) Limited
103-105 Bath Road
Slough Berks SL1 3UH / GB
Opponent's representative
Hall, Marina, et al, et al
Reckitt Benckiser plc, Group Patents Department, Dansom Lane
Hull HU8 7DS / GB
25.09.2003Invitation to proprietor to file observations on the notice of opposition
31.03.2004Reply of patent proprietor to notice(s) of opposition
10.05.2005Date of oral proceedings
06.06.2005Despatch of minutes of oral proceedings
18.12.2006Despatch of a communication from the opposition division (Time limit: M06)
25.06.2007Reply to a communication from the opposition division
12.06.2008Despatch of a communication from the opposition division (Time limit: M02)
21.08.2008Reply to a communication from the opposition division
14.11.2008Despatch of interlocutory decision in opposition
24.11.2008Legal effect of interlocutory decision in opposition
10.03.2009Despatch of communication that the patent will be maintained as amended
22.06.2009Fee for printing new specification paid
Appeal following opposition28.06.2005Appeal received No.  T0811/05
04.10.2005Statement of grounds filed
19.10.2006Result of appeal procedure: continuation of opposition procedure
19.10.2006Date of oral proceedings
26.10.2006Minutes of the oral proceedings despatched
Fees paidRenewal fee
04.01.1999Renewal fee patent year 03
05.01.2000Renewal fee patent year 04
02.01.2001Renewal fee patent year 05
02.01.2002Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [2003/20]GR20.11.2002
Cited inInternational search[A]EP0247983  (HAESSLE AB [SE]);
 [X]EP0338861  (WALTON SA [ES]);
 [A]EP0365947  (PHARMACIA AB [SE]);
 [X]US5244670  (UPSON JAMES G [US], et al);
 [A]  - TAKEUCHI K. ET AL., "Healing Process of Duodenal Ulcers Induced by Indomethacin Plus Histamine in Rats", CAPLUS, Database accession no. 1989:490176, XP002988505
    [ ] - DIGESTION, (1989), vol. 42, no. 4, pages 202 - 211
Examination   - STN INTERNATIONAL, File CAPLUS, CAPLUS Accession No. 1989:490176, K. TAKEUCHI et al., "Healing Process of Duodenal Ulcers Induced by Indomethacin Plus Histamine in Rats"; & DIGESTION, (1989), 42(4), 202-11.
OppositionJP2013706495
 EP0290229
 EP0294933
 EP0391518
 EP0290229
 EP0294933
 EP0496437
 WO9321932
 EP0600725
 WO9501780
 WO9510264
 EP0496437
 EP0723777
 EP0761212
 EP0600725
    - A. SANDBERG ET AL., EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, (1988), vol. 33, pages 53 - 57
    - J.-P. DECHESNE, INTERNATIONAL JOURNAL OF PHARMACEUTICS, (1987), vol. 37, pages 203 - 209
    - P. LINDBERG ET AL., MEDICAL RESEARCH REVIEWS, (1990), vol. 10, no. 1, pages 1 - 54
    - H.A.R.E. TUYNMAN ET AL., BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, (1987), vol. 24, pages 833 - 835
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.